These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 12511533)

  • 41. Characteristics of 9194 patients with left ventricular hypertrophy: the LIFE study. Losartan Intervention For Endpoint Reduction in Hypertension.
    Dahlöf B; Devereux RB; Julius S; Kjeldsen SE; Beevers G; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    Hypertension; 1998 Dec; 32(6):989-97. PubMed ID: 9856962
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Use of the signal-averaged QRS duration for diagnosing left ventricular hypertrophy in hypertensive patients.
    Fragola PV; De Nardo D; Calò L; Cannata D
    Int J Cardiol; 1994 May; 44(3):261-70. PubMed ID: 8077072
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Relation between electrocardiography and echocardiography for left ventricular mass in mild systemic hypertension (results from Treatment of Mild Hypertension Study).
    Crow RS; Prineas RJ; Rautaharju P; Hannan P; Liebson PR
    Am J Cardiol; 1995 Jun; 75(17):1233-8. PubMed ID: 7778546
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Influence of obesity on the diagnostic value of electrocardiographic criteria for detecting left ventricular hypertrophy.
    Abergel E; Tase M; Menard J; Chatellier G
    Am J Cardiol; 1996 Apr; 77(9):739-44. PubMed ID: 8651126
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gender differences and the electrocardiogram in left ventricular hypertrophy.
    Okin PM; Roman MJ; Devereux RB; Kligfield P
    Hypertension; 1995 Feb; 25(2):242-9. PubMed ID: 7843774
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The relationship between isolated nocturnal hypertension and left ventricular hypertrophy].
    Lu L; Li Y; Huang QF
    Zhonghua Nei Ke Za Zhi; 2008 Oct; 47(10):819-22. PubMed ID: 19080140
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Marked regional left ventricular heterogeneity in hypertensive left ventricular hypertrophy patients: a losartan intervention for endpoint reduction in hypertension (LIFE) cardiovascular magnetic resonance and echocardiographic substudy.
    Biederman RW; Doyle M; Young AA; Devereux RB; Kortright E; Perry G; Bella JN; Oparil S; Calhoun D; Pohost GM; Dell'Italia LJ
    Hypertension; 2008 Aug; 52(2):279-86. PubMed ID: 18606908
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Improved electrocardiographic diagnosis of left ventricular hypertrophy.
    Schillaci G; Verdecchia P; Borgioni C; Ciucci A; Guerrieri M; Zampi I; Battistelli M; Bartoccini C; Porcellati C
    Am J Cardiol; 1994 Oct; 74(7):714-9. PubMed ID: 7942532
    [TBL] [Abstract][Full Text] [Related]  

  • 49. T-wave axis deviation and left ventricular hypertrophy interaction in diabetes and hypertension.
    Assanelli D; Di Castelnuovo A; Rago L; Badilini F; Vinetti G; Gianfagna F; Salvetti M; Zito F; Donati MB; de Gaetano G; Iacoviello L;
    J Electrocardiol; 2013; 46(6):487-91. PubMed ID: 24011993
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prognostic value of changes in the electrocardiographic strain pattern during antihypertensive treatment: the Losartan Intervention for End-Point Reduction in Hypertension Study (LIFE).
    Okin PM; Oikarinen L; Viitasalo M; Toivonen L; Kjeldsen SE; Nieminen MS; Edelman JM; Dahlöf B; Devereux RB;
    Circulation; 2009 Apr; 119(14):1883-91. PubMed ID: 19332468
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prognostic value of a new electrocardiographic method for diagnosis of left ventricular hypertrophy in essential hypertension.
    Verdecchia P; Schillaci G; Borgioni C; Ciucci A; Gattobigio R; Zampi I; Porcellati C
    J Am Coll Cardiol; 1998 Feb; 31(2):383-90. PubMed ID: 9462583
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Regression of electrocardiographic left ventricular hypertrophy during antihypertensive therapy and reduction in sudden cardiac death: the LIFE Study.
    Wachtell K; Okin PM; Olsen MH; Dahlöf B; Devereux RB; Ibsen H; Kjeldsen SE; Lindholm LH; Nieminen MS; Thygesen K
    Circulation; 2007 Aug; 116(7):700-5. PubMed ID: 17664372
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Importance of the electrocardiographic strain pattern in patients with resistant hypertension.
    Salles G; Cardoso C; Nogueira AR; Bloch K; Muxfeldt E
    Hypertension; 2006 Sep; 48(3):437-42. PubMed ID: 16880349
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Electrocardiographic criteria for left ventricular hypertrophy and cardiovascular risk in hypertensives. VIIDA study].
    González-Juanatey JR; Cea-Calvo L; Bertomeu V; Aznar J;
    Rev Esp Cardiol; 2007 Feb; 60(2):148-56. PubMed ID: 17338880
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Correlation between global longitudinal strain and QRS voltage on electrocardiogram in patients with left ventricular hypertrophy.
    Beladan CC; Popescu BA; Calin A; Rosca M; Matei F; Gurzun MM; Popara AV; Curea F; Ginghina C
    Echocardiography; 2014 Mar; 31(3):325-34. PubMed ID: 24015855
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Arrhythmogenicity in left ventricular hypertrophy in mild to moderate arterial hypertension].
    Franchi F; Michelucci A; Padeletti L; Monopoli A; Fabbri G; Cersosimo RM; Mezzani A
    G Ital Cardiol; 1992 Aug; 22(8):905-18. PubMed ID: 1478391
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Distinct role of electrocardiographic criteria in echocardiographic diagnosis of left ventricular hypertrophy according to age, in the general population: the Ikaria Study.
    Tsiachris D; Chrysohoou C; Oikonomou E; Lazaros G; Dimitriadis K; Maragiannis D; Roussos D; Andreou I; Tsantilas A; Christoforatou E; Pitsavos C; Panagiotakos D; Stefanadis C
    J Hypertens; 2011 Aug; 29(8):1624-32. PubMed ID: 21610511
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New gender-specific partition values for ECG criteria of left ventricular hypertrophy: recalibration against cardiac MRI.
    Alfakih K; Walters K; Jones T; Ridgway J; Hall AS; Sivananthan M
    Hypertension; 2004 Aug; 44(2):175-9. PubMed ID: 15226274
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Left ventricular filling patterns in patients with systemic hypertension and left ventricular hypertrophy (the LIFE study). Losartan Intervention For Endpoint.
    Wachtell K; Smith G; Gerdts E; Dahlöf B; Nieminen MS; Papademetriou V; Bella JN; Ibsen H; Rokkedal J; Devereux RB
    Am J Cardiol; 2000 Feb; 85(4):466-72. PubMed ID: 10728952
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effect of electrocardiographic left ventricular hypertrophy on left ventricular systolic function in systemic hypertension (The LIFE Study). Losartan Intervention For Endpoint.
    Wachtell K; Rokkedal J; Bella JN; Aalto T; Dahlöf B; Smith G; Roman MJ; Ibsen H; Aurigemma GP; Devereux RB
    Am J Cardiol; 2001 Jan; 87(1):54-60. PubMed ID: 11137834
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.